The 11th International Conference on cGMP 2024: recent trends and developments in cGMP research —meeting report
ACEi Angiotensin-converting-enzyme inhibitor ANP Atrial natriuretic peptide ARB Angiotensin II receptor blocker BNP B-type natriuretic peptide BAT Brown adipose tissue BH 4 Tetrahydrobiopterin BP Blood pressure cAMP 3',5'-CAMP: cyclic adenosine monophosphate cCMP 3',5'-CCMP: cyclic cytidine monophosphate cGK CGMP-dependent protein kinase, aka
Authors
- Friederike Cuello (ORCID: https://orcid.org/0000-0003-1612-1715)
- Michael Russwurm (ORCID: https://orcid.org/0000-0003-2947-9097)
- Miriam M. Cortese‐Krott (ORCID: https://orcid.org/0000-0002-0593-1192)
- Jan R. Kraehling (ORCID: https://orcid.org/0000-0002-0979-2900)
Institutions
- Universität Hamburg (DE)
- University of Potsdam (DE)
- University of Applied Sciences Potsdam (DE)
- Karolinska Institutet (SE)
- University Medical Center Hamburg-Eppendorf (DE)
- German Centre for Cardiovascular Research (DE)
- Heinrich Heine University Düsseldorf (DE)
- Bayer (Germany) (DE)
Publication Details
- Journal
- Naunyn-Schmiedeberg s Archives of Pharmacology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1007/s00210-025-04059-1
- Citations
- 1
- Primary Topic
- Nitric Oxide and Endothelin Effects
- Type
- article
- Field-Weighted Citation Impact
- 1.16